| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.4307 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.6268 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.7625 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.807 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9161 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 0.9391 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.0609 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1253 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 1.1519 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 3.3449 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 4.1581 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 11.569 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|